A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety of TOL-3021 in Patients with New Onset or Established Type 1 Diabetes Mellitus
Details
Age
Adult
Type of Study
Treatment
Locations
Barbara Davis Center
Principal Investigator
Peter Gottlieb, MD
Study ID
Protocol Number: 19-0606
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers